Silverarc Capital Management, LLC Adc Therapeutics Sa Transaction History
Silverarc Capital Management, LLC
- $353 Million
- Q2 2024
A detailed history of Silverarc Capital Management, LLC transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 1,768,770 shares of ADCT stock, worth $5.34 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
1,768,770
Previous 501,222
252.89%
Holding current value
$5.34 Million
Previous $2.25 Million
148.4%
% of portfolio
1.59%
Previous 0.76%
Shares
2 transactions
Others Institutions Holding ADCT
# of Institutions
78Shares Held
52.8MCall Options Held
300KPut Options Held
59.3K-
Redmile Group, LLC San Francisco, CA15.3MShares$46.1 Million3.15% of portfolio
-
Prosight Management, LP Dallas, TX9.57MShares$28.9 Million9.45% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.32MShares$13 Million0.33% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$10.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.97MShares$8.95 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $234M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...